166 related articles for article (PubMed ID: 29338462)
21. Sham-Controlled Trial Questions Benefit of Stents for Stable Angina.
Kuehn BM
Circulation; 2018 Jan; 137(5):519-520. PubMed ID: 29378758
[No Abstract] [Full Text] [Related]
22. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
[TBL] [Abstract][Full Text] [Related]
23. Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us?
Kulik A
Curr Opin Cardiol; 2017 Nov; 32(6):707-714. PubMed ID: 28834794
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous revascularization improves outcomes in patients with prior coronary artery bypass surgery.
Gyenes G; Norris CM; Graham MM;
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E148-54. PubMed ID: 23208677
[TBL] [Abstract][Full Text] [Related]
25. Recanalization of isolated chronic total occlusions in patients with stable angina.
Jaguszewski M; Targonski R; Fijalkowski M; Masiewicz E; Dubaniewicz W; Templin C; Koprowski A; Ciecwierz D; Nallamothu BK; Rynkiewicz A
Int J Cardiol; 2013 Aug; 167(4):1542-6. PubMed ID: 22578737
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of randomized trials.
D'Ascenzo F; Barbero U; Moretti C; Palmerini T; Della Riva D; Mariani A; Omedè P; DiNicolantonio JJ; Biondi-Zoccai G; Gaita F
Contemp Clin Trials; 2014 May; 38(1):51-8. PubMed ID: 24657881
[TBL] [Abstract][Full Text] [Related]
27. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
28. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
Park KW; Kang SH; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Hur SH; Ryu JK; Lee BR; Park YW; Chae IH; Kim HS;
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2805-16. PubMed ID: 24814486
[TBL] [Abstract][Full Text] [Related]
29. Comparison of clinical outcomes according to presentation of angina pectoris versus acute myocardial infarction in patients who underwent a percutaneous coronary intervention with a drug-eluting stent.
Seo SM; Kim TH; Koh YS; Her SH; Shin DI; Park HJ; Kim PJ; Park CS; Lee JM; Kim DB; Kim HY; Chang K; Yoo KD; Jeon DS; Chung WS; Seung KB;
Coron Artery Dis; 2016 Mar; 27(2):143-50. PubMed ID: 26693807
[TBL] [Abstract][Full Text] [Related]
30. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.
Cho KI; Ann SH; Singh GB; Her AY; Shin ES
PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
[TBL] [Abstract][Full Text] [Related]
32. Routine angiographic follow-up versus clinical follow-up in patients with diabetes following percutaneous coronary intervention with drug-eluting stents in Korean population.
Kim YH; Her AY; Choi BG; Choi SY; Byun JK; Park Y; Baek MJ; Ryu YG; Mashaly A; Jang WY; Kim W; Park EJ; Choi JY; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Rha SW
Diabetes Res Clin Pract; 2018 Apr; 138():138-148. PubMed ID: 29428458
[TBL] [Abstract][Full Text] [Related]
33. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
[TBL] [Abstract][Full Text] [Related]
34. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
Kurlansky P; Herbert M; Prince S; Mack MJ
Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
[TBL] [Abstract][Full Text] [Related]
35. Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).
Smits PC; Vlachojannis GJ; McFadden EP; Royaards KJ; Wassing J; Joesoef KS; van Mieghem C; van de Ent M
JACC Cardiovasc Interv; 2015 Aug; 8(9):1157-1165. PubMed ID: 26210806
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
Pursnani S; Korley F; Gopaul R; Kanade P; Chandra N; Shaw RE; Bangalore S
Circ Cardiovasc Interv; 2012 Aug; 5(4):476-90. PubMed ID: 22872053
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
[TBL] [Abstract][Full Text] [Related]
38. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
[TBL] [Abstract][Full Text] [Related]
40. Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.
Khattab AA; Knecht M; Meier B; Windecker S; Schmid JP; Wilhelm M; Saner H
Eur J Prev Cardiol; 2013 Oct; 20(5):743-9. PubMed ID: 22547410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
